Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications.
Zotz
R B
RB
Department of Hemostasis and Transfusion Medicine, University Medical Center, Düsseldorf, Germany. zotz@med.uni-duesseldorf.de
Gerhardt
A
A
Scharf
R E
RE
D000026:Abortion, Habitual / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D000328:Adult; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D011292:Premedication; D018570:Risk Assessment; D019851:Thrombophilia / Q000188:drug therapy*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006493:Heparin